As GLP-1 use rises among women, doctors warn stopping the drugs before pregnancy may trigger weight regain, metabolic rebound and fertility shifts, raising risks of gestational diabetes and ...

PFAS (forever chemicals) are associated with higher odds of gestational diabetes and increased markers of insulin resistance ...

newborn baby and mother Maternal glycemia during pregnancy may influence childhood glucose and insulin resistance regardless of BMI and family history of diabetes. During pregnancy, across the ...

GLP-1 weight-loss drugs are in the news because so many people are using them to treat obesity and diabetes. With so many ...

Greater exposure to per- and polyfluoroalkyl substances may increase odds for gestational diabetes and worse insulin ...

WASHINGTON, DC — Research recently published on diabetes in pregnancy has offered insight on issues such as earlier pharmacologic treatment of gestational diabetes (GDM) and combination treatment with ...

Exposure to per- and polyfluoroalkyl substances (PFAS), a class of highly persistent environmental chemicals commonly ...

Complications like gestational diabetes, preeclampsia, severe hypertension, or delivering a high-birth-weight baby may feel like problems that end after delivery, but for many women, they represent ...

Find out how PFAS exposure may increase gestational diabetes risk and disrupt insulin regulation during pregnancy, according ...

Insulin resistance, or low insulin sensitivity, happens when cells throughout the body don’t respond properly to the hormone insulin, especially cells in: Insulin is a pancreatic hormone that allows ...